Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

Active, not recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions

Biliary Tract CancerBiliary Tract Cancers (BTC)

Interventions

DRUG

Chemotherapy

Any chemotherapy regimen that is used in the adjuvant setting

Trial Locations (1)

Ankara University Faculty of Medicine Department of Medical Oncology, Ankara

All Listed Sponsors

collaborator

Turkish Oncology Group

NETWORK

lead

Ankara University

OTHER